Research

Innovative scientific advancements to transform the future of patient care

Overview

Pioneering research, collaborative spirit, and life-changing advancements are hallmarks of UCSF Otolaryngology research. Join us on this journey to shape the future of otolaryngology.

The value of research

UCSF's Otolaryngology Department scientists helm a vibrant hub of exploration, constantly pushing the boundaries of scientific discovery. Our commitment to research is what makes us exceptional. This dedication translates into tangible advancements that impact lives every day. What sets us apart is our culture of collaboration, fostering a diverse, interdisciplinary approach for creating solutions. 

Our mission is to pioneer a deeper understanding of the biological underpinnings of our field. Through a commitment to supporting emerging basic scientists and partnering with both public and private sectors, we're advancing the frontiers of otolaryngology research. UCSF Otolaryngology is not just about the present; it's about shaping the future of healthcare. 

Clinical trials


Prospective, Open Label, Multicenter Study of the Aerin Medical RhinAer® ARC Stylus for Chronic Rhinitis to continue to evaluate the effectiveness of the RhinAer® ARC Stylus for treating the posterior nasal nerve area to improve symptoms in adults diagnosed with chronic rhinitis.

Sudy Number: NCT04614324

The primary objective of this double-blind, randomized, placebo-controlled, multicenter clinical trial is to evaluate the safety of Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) during the 24 months following 2 consecutive treatments of tongue dysphagia in male and female patients who have undergone surgery and/or chemo- and/or radiotherapy for squamous cell cancer of the oropharynx.

Click here for more information. Click here for a short video about the study.

Study Number: NCT05421689

Key individuals

Principal Investigator
Clark Rosen, MD

Please go to the Balance & Falls Center Research page, to learn more.

Key Individuals

Principal Investigator: Jeffery Sharon, MD
Study Coordinator: Maxwell Hum ([email protected])

Early identification and intervention for hearing loss in children is critical to prevent future speech, language, educational, and cognitive impairment. Though universal newborn hearing screening has been highly successful at identifying deaf and hard of hearing babies at birth, there is no subsequent mechanism for hearing screening until the start of school. Currently, preschool hearing screening is highly variable, and outcomes are uncertain. We have partnered with the San Francisco Department of Public Health to optimize screening and follow-up strategies in preschoolers. In an accompanying study, we are recruiting children aged 3-10 with hearing loss or normal hearing, to test different ways of screening for hearing loss. Participants will be compensated for their time. This study will help us better identify hearing loss in preschoolers so they can receive appropriate intervention and be ready for school entry.

Eligiibility: children aged 3-10 years of age with permanent hearing loss, or with normal hearing.

Study number: 15-16293

(415) 530-0830
See all clinical trials